2014-2015 Student Fellowship
Petrie-Flom Center, Harvard Law School

Deadline: May 19, 2014

>The Center and Student Fellowship.  The Petrie-Flom Center for Health Law Policy, Biotechnology... Read More

Health Law Workshop: W. Nicholson Price II

Monday, October 17, 2016 5:00 PM
Health Law Workshops
2016-2017
Hauser Hall, Room 104
Harvard Law School, 1575 Massachusetts Ave., Cambridge, MA

>Nicholson Price is an Assistant Professor at the University of Michigan School of Law, where he... Read More

​‘The Greed Is Astounding’:

Kaiser Health News, September 22, 2016

KHN Morning Briefing: Summaries of health policy coverage from major news organization

s

But He...

Read More

It’s Not Just For Kids:

Kaiser Health News, September 21, 2016
by Julie Appleby and Mary Agnes Carey

Even as the cost of EpiPens dramatically rose, so too did the number of prescriptions written for pa...

Read More

5 reasons why no one has built a better EpiPen

STAT, September 9, 2016
by Meghana Keshavan, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] But critics say Mylan has little incentive to improve EpiPens: “If you’re the...

Read More

How Mylan cornered the consumer epinephrine market

MedCityNews, September 8, 2016
by Pauline Bartolone, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] The New York state attorney general’s office announced Tuesday it will investigate...

Read More

Euro Drug Pricing’s Tradeoffs May Limit Appeal In US

Law360, September 8, 2016
by Dani Kass, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] Going forward, an influx of bills targeting drug prices could be introduced, but few are...

Read More

EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog

Kaiser Health News, September 6, 2016
by Sydney Lupkin

Consumers and Congress members pushing for cheaper alternatives to the EpiPen and other high-priced...

Read More

On Heels Of EpiPen Outrage, Clinton Unveils Plan Targeting High Drug Prices

Kaiser Health News, September 6, 2016

KHN Morning Briefing: Summaries of health policy coverage from major news organization

s

Hillar...

Read More

Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen

New York Times, August 29, 2016
by Andrew Pollack

In its latest move to quell outrage over its price increases, the maker of the EpiPen has resor...

Read More

Call for Proposals: BioIP Faculty Workshop
ASMLE, Loyola University of Chicago School of Law

Deadline: October 16, 2016

The American Society for Law, Medicine & Ethics (ASLME) is pleased to announce the second annual...

Read More

Bioethics: The Law, Medicine, and Ethics of Reproductive Technologies and Genetics

Petrie-Flom Center, Course begins September 6, 2016. Register now!

>Bioethics: The Law, Medicine, and Ethics of Reproductive Technologies and Genetic

s

An introduction...

Read More

Health Law Professor
University of Pittsburgh School of Law

Deadline: October 15, 2016

The University of Pittsburgh School of Law invites applications for a tenure-stream position beginni...

Read More

The Relationship Between Bioethics and U.S. Health Law:

In The Oxford Handbook of U.S. Healthcare Law, I. Glenn Cohen, Allison K. Hoffman, and William M. Sage, eds., May 2016
by I. Glenn Cohen (Faculty Director)

>Abstract: ;This chapter explores the way bioethics is taught as part of U.S. health law. It begi... Read More

Divided Infringement and the Doctor-Patient Relationship

IP Theory, 2016 (Forthcoming)
by Rachel E. Sachs (Academic Fellow)

>Abstract: ;     
; With its recent en banc decision in Akamai v. Limeligh... Read More

Resolving Reverse-Payment Settlements with the Smoking Gun of Stock Price Movements

81 Iowa Law Review 1581, 2016
by Thomas G. McGuire, Keith Drake, Einer Elhauge (Founding Faculty Director), Raymond S. Hartman, Martha Starr

>Abstract: ;The Supreme Court recently held that in reverse-payment settlements of drug patent di... Read More

Prizing Insurance: Prescription Drug Insurance as Innovation Incentive,

Harvard Journal of Law and Technology, Vol. 30, No. 1 (forthcoming)
by Rachel E. Sachs

Abstract: 

;

A problem perennially facing scholars of both intellectual property and health law...

Read More

Promoting Healthcare Innovation on the Demand Side,

U of Michigan Law & Econ Research Paper No. 16-008; U of Michigan Public Law Research Paper No. 503
by Rebecca Eisenberg and W. Nicholson Price II (Academic Fellow Alumnus)

Abstract

:

Innovation policy often focuses on the incentives of firms that sell new products. But op...

Read More

Health Law Workshop: Robert Cook-Deegan

Monday, April 18, 2016 5:00 - 7:00 PM
Health Law Workshops
2015-2016
Hauser Hall 105
Harvard Law School, 1575 Massachusetts Ave., Cambridge, MA

>Download the materials for the presentation: "Mining the Genomic Data Mountain: Legal and Polic... Read More

2016 Global School Health Rights Litigation Course
O’Neill Institute and Harvard FXB

Deadline: June 1, 2016

Join the O’Neill Institute and Harvard FXB for the 2016 Global School Health Rights Litigation...

Read More

New Journal of Law & Biosciences featuring Harvard student work

Journal of Law and the Biosciences (JLB), Vol. 3, Issue 1 (April 2016)

The ;Journal of Law and the Biosciences, the open-access journal launched in 2014 by the Pe...

Read More

How to Make the Most of Drugs We Already Have

The Upshot, New York Times, February 22, 2016
by By Austin Frakt, citing Ben Roin (Academic Fellow alumnus)

From the articl

e

[...] Moreover, if a drug company cannot ascertain the problem for which a prescri...

Read More

The Unpatentable Microbiome

New England Regional Junior Faculty Scholarship Workshop, February 12, 2016
by Rachel E. Sachs (Academic Fellow)

>Presentation Abstract: 

;

Scientists have recently begun to appreciate the important role played...

Read More

Fourth Annual Health Law Year in P/Review

Friday, January 29, 2016 8:00 AM - 5:00 PM
Conferences
2015-2016
Wasserstein Hall, Milstein West AB
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

>Couldn't attend in person? Learn more about the event

:
  • Learn more about the presentations -...

Read More

Visiting Health/IP Law Professor
Indiana University Robert H. McKinney School of Law

Deadline: February 18, 2016

The Indiana University Robert H. McKinney School of Law invites applications for a 2016-17...

Read More

Jaharis Faculty Fellow in Health Law and Intellectual Property
DePaul University College of Law

Deadline: Open until filled.

Jaharis Faculty Fellow in Health Law and Intellectual Propert

y

A new endowment at the DePaul Univer...

Read More

Heidi Williams wins MacArthur “genius grant”

MIT News, September 29, 2015
by Peter Dizikes, on Heidi Williams (Student Fellow Alumna)

From the article

:

MIT economist Heidi Williams, whose scholarly work looks at the effects of patent...

Read More

How Patent Law Can Block Even Lifesaving Drugs

New York Times, September 28, 2015
by Austin Frakt, quoting Benjamin Roin (Former Faculty Co-Director & Academic Fellow; Current Affiliated Faculty)

From the article

:

To see evidence of this, just look at the behavior of pharmaceutical firms. When...

Read More

Big Data, Patents, and the Future of Medicine

Cardozo Law Review, Forthcoming , September 13, 2015
by W. Nicholson Price II (Academic Fellow Alumnus)

>Abstract: 

;

Big data has tremendous potential to improve health care. Unfortunately, intellectu...

Read More

Review of Innovation Law and Policy: Preserving the Future of Personalized Medicine

Written Description Blog, July 27, 2015
by Lisa Ouellette

From the review

:

I highly recommend two recently posted articles on declining innovation incentives...

Read More

Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

Nature Biotechnology, July 2015, Vol. 33, No. 7
by W Nicholson Price II (Academic Fellow alumnus) & Timo Minssen (past Visiting Scholar)

Petrie-Flom Academic Fellow alumnus ;Nicholson Price, now an Assistant Professor at the&nbs...

Read More

Innovation Law and Policy:

U. C. Davis Law Review, Forthcoming 2016
by Rachel E. Sachs

Academic Fellow Rachel E. Sachs has a new article forthcoming in 2016 on law and the future of perso...

Read More

Health Law Workshop: Rachel E. Sachs

Monday, April 13, 2015 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

>Presentation Title: "Rethinking the Incentives/Access Dichotomy: Prescription Drug Reimbursement as... Read More

Are trade secrets delaying biosimilars?

Science, April 10, 2015
by W. Nicholson Price II (Academic Fellow Alumnus) and Arti K. Rai

Petrie-Flom Academic Fellow alumnus Nicholson Price, now an Assistant Professor at the Uni...

Read More

Health Law Workshop: Amy Kapczynski

Monday, February 23, 2015 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

Professor Kapczynski's presentation, "Order Without Intellectual Property Law:  The Flu Net...

Read More

Clinical Trial Recruitment: Problems, Misconceptions, and Possible Solutions,

Petrie-Flom Center, February 5, 2015

On January 19 - 21, 2015, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics...

Read More

Third Annual Health Law Year in P/Review

Friday, January 30, 2015 7:45 AM - 5:00 PM
Conferences
2014-2015
Wasserstein Hall, Milstein East AB
1585 Massachusetts Avenue, Cambridge, MA

>Couldn't make it in person? Check out the individual sessions in the videos linked above and&nbs... Read More

The Future of Personalized Medicine

Hosted by The Future Society at the Harvard Kennedy School, January 28, 2015
by Rachel E. Sachs

On January 28, 2015, Academic Fellow Rachel E. Sachs spoke to the Future Society at the Harvard Kenn...

Read More

First biosimilar drug set to enter US market:

Nature, January 13, 2015
by Heidi Ledford, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] The FDA is expected to make a final decision by May. But even as Sandoz prepares to sell its d...

Read More

The New Model of Interest Group Representation in Patent Law

Yale Journal of Law and Technology, October 1, 2014
by Rachel Sachs (Academic Fellow)

From the article

:

Traditional public choice theory postulates that interest group representation is...

Read More

Post-Trial Responsibilities:: Ethics and Implementation

Thursday, September 18, 2014 7:30 AM - 5:30 PM
Conferences
2014-2015
Wasserstein Hall, Milstein East AB
1585 Massachusetts Ave., Cambridge, MA

Conference Description 

;

Who:

Clinical research sponsors, investigators, funders, regulators,...

Read More

Call for Submissions: Journal of Law and the Biosciences

Deadline: Rolling admission.

>Journal of Law and the Biosciences (JLB) is actively soliciting original manuscripts, responses... Read More

Welcome 2014-2016 Academic Fellow Rachel Sachs!

Petrie-Flom Center, April 17, 2014

The Petrie-Flom Center is pleased to announce the new 2014-2016 Academic Fellow, Rachel Sachs. ...

Read More

Make it Work!:

Harvard Law Review 128, 2014
by I. Glenn Cohen (Faculty Co-Director)

This short essay is part of a Harvard Law Review Symposium honoring Justice Breyer on his 20th Year...

Read More

The “Problem” with the European Problem/Solution Approach to Inventive Step

Los Angeles Intellectual Property Law Association, Wegner's Writings, February 24, 2014
by Harold C. Wegner, reviewing Timo Minssen (Petrie-Flom Visiting Scholar)

>From the review: Patent applicants seeking to gain global patent protection beyond their home c... Read More

Patent Trolling:

by Robin Feldman and W. Nicholson Price II (Petrie-Flom Academic Fellow)

>Abstract

:

Patent trolls — also known variously as non-practicing entities, patent assertion e...

Read More

Legal Aspects of Biobanking as Key Issues for Personalized Medicine & Translational Exploitation

by Timo Minssen (Petrie-Flom Visiting Scholar) and Jens Schovsbo

>Abstract: ;This perspective-article provides an overview on selected legal aspects of biobanking... Read More

NEW BOOK: Science and Technology in International Economic Law:

Routledge, 2014
by Bryan Mercurio and Kuei-Jung Ni (Petrie-Flom Visiting Scholar), editors

Science and technology plays an increasingly important role in the continued development of internat...

Read More

Do Fixed Patent Terms Distort Innovation?:

Public Health Law & Policy e-Journal 5, no. 64, December 4, 2013
by Eric B. Budish, Benjamin N. Roin, and Heidi Williams

>Abstract: ;Patents award innovators a fixed period of market exclusivity, e.g., 20 years in the... Read More

Genes without Patents

Harvard Gazette, November 14, 2013
by Alvin Powell, featuring I. Glenn Cohen

As Supreme Court Justice Elena Kagan questioned Myriad Genetics’ attorney about patenting gene...

Read More

Chris Hansen on “Dis-Owning Nature: The BRCA Gene Patents and the Supreme Court”

Program on Science, Technology, & Society at HKS, November 12, 2013
by Featuring I. Glenn Cohen as a discussant

ABOUT THE SPEAKE

R

Chris Hansen joined the ACLU in 1973. He spent 10 years at the NYCLU specializing...

Read More

Pharma manufacturing woes dog industry

Chemistry World, October 23, 2013
by Sarah Moulton, quoting W. Nicholson Price II

[...] While many of these problems arise from quality control failures, according to Nicholson...

Read More

Praise for “Making Do in Making Drugs” by W. Nicholson Price II

Written Description: Patent & IP Blog, Reviewing Recent Scholarship on Patent Law, IP Theory, and Innovation, September 28, 2013
by Camilla Alexandra Hrdy

"'M&M chocolate candies are made with a precision far beyond the capabilities of many drug m...

Read More

Making Do in Making Drugs:

Boston College Law Review, forthcoming
by W. Nicholson Price II

>Abstract:  

;

Drug recalls, contamination events, and shortages are on the rise, but drug compan...

Read More

Association for Molecular Pathology v. Myriad Genetics

by Oyez Project

In June 2013, the Supreme Court held that naturally occurring gene sequences and their naturally occ...

Read More

Myriad Gene Patent Litigation

Genomics Law Report

This link provides several viewpoints regarding the Myriad Genetics case.

... Read More

7 Takeaways from Supreme Court’s Gene Patent Decision

Daily News, National Geographic

Shortly after the Supreme Court ruling in Myriad, this article summarizes the implications of the de...

Read More

Gene Patents

The Hastings Center Bioethics Briefing Book
by Robert Cook-Deegan

Intended for a lay audience, this chapter outlines key issues in the debate about gene patents and s...

Read More

Patents in Genomics and Human Genetics

Annual Review of Genomics and Human Genetics
by Robert Cook-Deegan and Christopher Heaney

This article provides a more detailed and scholarly overview of the issues.

... Read More

Issues and Case Studies in Clinical Trial Data Sharing:: What Have We Learned?

Sunday, May 12, 2013
Conferences
2012-2013
Wasserstein Hall, Milstein East, Harvard Law School
1585 Massachusetts Ave., Cambridge, MA
Watch Event Recordings

Objectives

:
  • To convene key global stakeholders on a neutral platform to review evidence from rece...
Read More

Debunking the Myth that Whole-Genome Sequencing Infringes Thousands of Gene Patents

Nature Biotechnology
by Christopher M. Holman

This article addresses misconceptions regarding gene patents and whole-genome sequencing.

... Read More

Mayo Collaborative Services v. Prometheus Laboratories

by Oyez Project

In this case, the Supreme Court held that the processes involved in a test for proper dosages of dru...

Read More

Personalized Medicine Patenting

Wednesday, March 06, 2013
Lectures and Panels
2012-2013
Austin Hall 111, Harvard Law School
Watch Event Recordings

Pharmaceutical researchers pursue medical treatment and diagnostic methods to target diseases specif...

Read More

Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine

by Congressional Research Service

This article discusses the implications of the Mayo v. Prometheus decision, including its potential...

Read More

Patent Policy and Innovation

Friday, April 23, 2010
2009-2010

This panel focused on how patent law affects various industries differently. The pharmaceutical...

Read More

Developments and Implications of New Legislation on Follow-on Biologics

Wednesday, January 06, 2010
Lectures and Panels
2009-2010

This panel examined current legislative debates concerning the development of regulatory approv...

Read More

Medical Prize Funds:: An Alternative Reward Mechanism for Medical Innovation

Thursday, November 05, 2009
Lectures and Panels
2009-2010

Patenting and other rewards that rely on protected markets to encourage research investment in...

Read More

Pharmaceutical Research, Development, and Markets

Friday, June 12, 2009
Conferences
2008-2009

Amidst this larger debate about drug prices and pharmaceutical innovation, there is a growing consen...

Read More